News
Scientists prove the implication of an amino acid transporter in age-related deafness
The CIBERER U730 and U731 units, led respectively by Virginia Nunes (IDIBELL, UB) and Manuel Palacín (IRBB, UB) have just published in eLife a study carried out in collaboration with the U761 units (Isabel Varela-Nieto, CSIC / UAM) and U716 (Mara Dierssen, CRG), as well as with international groups, Dr. Meritxell Espino (Sidra Medicine, Qatar) and Dr. […]
The IT-LIVER European consortium expands TGF-beta knowledge in liver cancer
The research of the TGF-beta and cancer group of the Bellvitge Biomedical Research Institute (IDIBELL) within the IT-LIVER (Inhibiting TGF-beta in liver diseases) consortium, a collaborative European action coordinated by Dr. Isabel Fabregat, has led to three new impact publications that offer new insights into the molecular mechanisms associated with the cytokine TGF-beta in liver […]
Àlex Vaquero is awarded 200,000 euros from Worldwide Cancer Research to better understand the origin of cancer
Dr. Àlex Vaquero, leader of the chromatin biology research group of the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded one of the prestigious grants from the Worldwide Cancer Research organization, worth 200,000 euros. The grant will fund a new project of this basic research group focused on the study of the mechanisms of tumor […]
EU empowers four IDIBELL researchers with Marie Sklodowska-Curie Individual Fellowships
Quatre ajuts concedits en la convocatòria amb més propostes presentades
The Cátedra Extraordinaria del Dolor honors Francisco Ciruela for the design of the first photoactive drug with analgesic action
Professor Francisco Ciruela, from the Faculty of Medicine and Health Sciences of the University of Barcelona, the Institute of Neurosciences of the UB and the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded the Preclinical Research Award from Cátedra Extraordinaria del Dolor of the University of Salamanca – Grünenthal Foundation. This prize awards a research with animal models, published in the […]
Successful first #Lindibell swing jam for biomedical research
Last Saturday, January 27th, the Casino of the Center of l’Hospitalet hosted the first Lindibell charity swing jam, the benefits of which will be used to fund some activitites for the young researchers from the Bellvitge Biomedical Research Institute of Bellvitge (IDIBELL). In this first edition, the initiative has raised € 550 thanks to the […]
Researchers identify a new NF-kB pathway regulatory mechanism linked to SirT6
Researchers from the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Àlex Vaquero, have proposed a new regulation mechanism of the NF-κB pathway, which is associated with accelerated cellular aging, based on the analysis of the function of the SirT6 protein. The results of their work, published in […]
Conxi Lázaro, Juani Fernández and Alberto Villanueva receive an NF Research Initiative grant to test combination therapies in MPNST
The group of dr. Conxi Lázaro, principal investigator of the Hereditary cancer research group of the Oncobell program (IDIBELL) and head of the Molecular diagnostic Unit of the Hereditary cancer program (ICO), has been awarded one of five preclinical research grants that NF Research Initiative, an initiative linked to Boston Children Hospital, annually offers. This […]
IDIBELL researchers successfully test a new combination therapy in sarcomas
Researchers of the Sarcoma group of the Oncobell program – Bellvitge Biomedical Research Institute (IDIBELL) have successfully tested a new combined therapy for the treatment of this rare, aggressive tumor type, which affects children and adults. The results of the clinical trial, published in Targeted Oncology, represent a successful step in the translational research strategy […]